# IL-6: A Marker for AML Chemo Sensitivity

> **NCT06486350** · — · RECRUITING · sponsor: **Fujian Medical University Union Hospital** · enrollment: 72 (estimated)

## Conditions studied

- AML, Adult

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06486350
- **Lead sponsor:** Fujian Medical University Union Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2024-10
- **Final completion:** 2025-06
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06486350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06486350, "IL-6: A Marker for AML Chemo Sensitivity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06486350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*